HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Soboll, G. Articles by Lunn, D. P. Search for Related Content PubMed PubMed Citation Articles by Soboll, G. Articles by Lunn, D. P. Agricola Articles by Soboll, G. Articles by Lunn, D. P.

Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes

¹ Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA
² Department of Biological Sciences, Macquarie University, Sydney, Australia
³ Department of Veterinary Sciences, University of Kentucky, Lexington, KY 40546, USA
⁴ Department of Veterinary Microbiology and Immunology, Washington State University, Pullman, WA 99164, USA
⁵ PowderJect Vaccines Inc., 585 Science Drive, Suite C, Madison, WI 53711, USA

Correspondence
Paul Lunn
lunnp{at}svm.vetmed.wisc.edu

Equine herpesvirus-1 (EHV-1) causes serious disease in horses throughout the world, despite the frequent use of vaccines. CTLs are thought to be critical for protection from primary and reactivating latent EHV-1 infections. However, the antigen-specificity of EHV-1-specific CTLs is unknown. The aim of this study was to identify EHV-1 genes that encode proteins containing CTL epitopes and to determine their MHC I (or ELA-A in the horse) restriction. Equine dendritic cells, transfected with a series of EHV-1 genes, were used to stimulate autologous CTL precursor populations derived from previously infected horses. Cytotoxicity was subsequently measured against EHV-1-infected PWM lymphoblast targets. Dendritic cells were infected with EHV-1 (positive control) or transfected with plasmids encoding the gB, gC, gD, gE, gH, gI, gL, immediate-early (IE) or early protein of EHV-1 using the PowderJect XR-1 research device. Dendritic cells transfected with the IE gene induced CTL responses in four of six ponies. All four of these ponies shared a common ELA-A3.1 haplotype. Dendritic cells transfected with gC, gD, gI and gL glycoproteins induced CTLs in individual ponies. The cytotoxic activity was ELA-A-restricted, as heterologous targets from ELA-A mismatched ponies were not killed and an MHC I blocking antibody reduced EHV-1-specific killing. This is the first identification of an EHV-1 protein containing ELA-A-restricted CTL epitopes. This assay can now be used to study CTL specificity for EHV-1 proteins in horses with a broad range of ELA-A haplotypes, with the goal of developing a multi-epitope EHV-1 vaccine.

This article has been cited by other articles:

				J. H. Kydd, N. J. Davis-Poynter, J. Birch, D. Hannant, J. Minke, J.-C. Audonnet, D. F. Antczak, and S. A. Ellis A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus 1 J. Gen. Virol., September 1, 2006; 87(9): 2507 - 2515. [Abstract] [Full Text] [PDF]